83-Year-Old Woman With No History of Gout and Serum Uric Level of 9.2 mg/dl, Who Underwent DECT (2013) of Right Foot Due to Right Ankle Pain and Swelling: (A) Coronal image through forefoot and (B) coronal image through ankle. Green pixels (arrows) observed in association with first and fourth metatarsophalangeal joints (A) and tibiotalar joint (B), consistent with monosodium urate deposition. Examination interpreted as positive for gout. Final clinical diagnosis by referring service was gout. Confirmatory

January 28, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), technological improvements, clinical practice changes, and growing experience among radiologists and referrers alike are contributing to the evolving role of dual-energy CT (DECT) in gout workup.

When comparing DECT examinations performed for gout in 2013 and 2019, the frequency of equivocal interpretations was significantly lower in 2019, “possibly related to interval technologic improvements,” lead researcher Francis I. Baffour, M.D., of Mayo Clinic in Rochester, MN concluded. “Negative examinations were less frequently followed by joint aspirations in 2019, possibly reflecting increasing clinical acceptance of the DECT results.”

Baffour and colleagues’ retrospective study included 100 consecutive adult patients who underwent DECT for gout evaluation in each of two periods, beginning in March 2013 and September 2019. DECT examinations in 2013 used a second-generation scanner (140 kV with 0.4 mm tin filter); in 2019, a third-generation scanner (150 kV with 0.6 mm tin filter) with improved spectral separation was used. Original DECT reports were classified as positive, negative, or equivocal for monosodium urate crystals indicative of gout. Joint aspirations occurring post-examination were recorded via medical record review.

Compared with the 2013 DECT examinations performed for suspected gout, those performed in 2019 had a significantly lower frequency of equivocal interpretations (16.0% vs. 33.0%, p<.001). Moreover, joint aspiration was significantly less likely to be performed after negative DECT interpretations in 2019 than in 2013 (2.1% vs. 17.4%, p=.02).

“The findings indicate an evolving role for DECT in the evaluation of gout following an institution’s routine adoption of the technology for this purpose,” the authors of this AJR article added.

For more information: www.arrs.org

Related content:

Advances in CT to Enhance Radiation Therapy Planning

New Study Shows Value of Low-concentration Iodine When Paired with Dual-Energy CT and DL Technique


Related Content

News | Computed Tomography (CT)

At the annual AHRA (American Healthcare Radiology Administrators) conference in Orlando, Florida, Bayer announced an ...

Time August 09, 2024
arrow
News | Computed Tomography (CT)

SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...

Time August 06, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

In the ever-evolving landscape of medical imaging, computed tomography (CT) stands out as a cornerstone technology ...

Time July 30, 2024
arrow
Videos | Radiology Business

Find actionable insights to achieve sustainability and savings in radiology in this newest of ITN’s “One on One” video ...

Time July 30, 2024
arrow
Feature | Radiology Business | By Christine Book

Across the healthcare industry, and, notably, throughout the radiology community in just the past few years, the focus ...

Time July 26, 2024
arrow
Feature | Mobile C-Arms | By Melinda Taschetta-Millane

Mobile C-arms continue to revolutionize medical imaging, offering versatility, mobility and real-time visualization ...

Time July 26, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
Subscribe Now